Schwalbe reinvents the valve and it's better than Presta, but is that enough to convince everyone to make the switch?
Shares in US biotech Y-mAbs Therapeutics have lost almost a third of their value after FDA advisors unanimously rejected its brain cancer therapy 131I-omburtamab in 16 to 0 vote. The Oncologic Drugs ...
The FDA has just handed an advantage to GlaxoSmithKline’s triple therapy for chronic obstructive pulmonary disease (COPD) by rejecting AstraZeneca’s PT010, a close competitor. AZ has confirmed that ...
The Cool Down on MSN
Handywoman demonstrates simple fix for common toilet problem: 'Extremely helpful'
A running toilet is not only annoying, it's also expensive. Here's how to easily fix a running toilet and save money.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results